Mission Wealth Management, LP Penumbra Inc Transaction History

Mission Wealth Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$151.88 - $228.5 $4,404 - $6,626	-29 Reduced 1.76%	1,622 $360,000
Q1 2021 May 10, 2021	SELL	$175.6 - $291.43 $263,400 - $437,145	-1,500 Reduced 47.6%	1,651 $447,000
Q4 2020 Jan 19, 2021	SELL	$174.98 - $272.83 $8,049 - $12,550	-46 Reduced 1.44%	3,151 $551,000
Q3 2020 Oct 16, 2020	SELL	$185.27 - $238.73 $370,540 - $477,460	-2,000 Reduced 38.48%	3,197 $621,000
Q2 2020 Aug 03, 2020	SELL	$153.32 - $191.72 $306,640 - $383,440	-2,000 Reduced 27.79%	5,197 $929,000
Q4 2019 Jan 21, 2020	SELL	$134.81 - $177.8 $340,530 - $449,122	-2,526 Reduced 25.98%	7,197 $1.18 Million
Q2 2019 Aug 09, 2019	SELL	$124.65 - $167.39 $249,300 - $334,780	-2,000 Reduced 17.06%	9,723 $1.56 Million
Q4 2018 Feb 08, 2019	SELL	$113.42 - $156.48 $117,956 - $162,739	-1,040 Reduced 8.15%	11,723 $1.43 Million
Q3 2018 Nov 01, 2018	SELL	$121.55 - $156.8 $850 - $1,097	-7 Reduced 0.05%	12,763 $1.91 Million
Q2 2018 Aug 08, 2018	SELL	$112.2 - $165.95 $280,500 - $414,875	-2,500 Reduced 16.37%	12,770 $1.76 Million
Q2 2017 Aug 11, 2017	BUY	N/A	15,270	15,270 $1.34 Million

383

29.6M

285K

168K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $7.26B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

Stay updated on Mission Wealth Management, LP with notifications on news.